Nuzenio

Rigel Pharmaceuticals

Rigel Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Rigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 13:27:26 GMTRigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts - simplywall.stsimplywall.st · Thu, 06 Aug 2026 06:47:05 GMTH.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - MoomooMoomoo · Wed, 05 Aug 2026 20:31:22 GMTRigel Pharmaceuticals: The Easy Money Has Been Made (Rating Downgrade) - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 18:29:23 GMTRigel Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:30:00 GMTRigel Pharma's Q2 beats on TAVALISSE sales but GAVRETO decline and cautious outlook lead to Hold rating. - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMTIs Rigel Pharmaceuticals (RIGL) Overvalued After Q2 Earnings Bea - GuruFocusGuruFocus · Wed, 05 Aug 2026 03:12:31 GMTRigel Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:RIGL) 2026-08-04 - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 03:03:30 GMT

Timeline

Fri, 07 Aug 2026 13:27:26 GMTRigel Pharmaceuticals Inc (RIGL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thu, 06 Aug 2026 06:47:05 GMTRigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts - simplywall.st
Wed, 05 Aug 2026 20:31:22 GMTH.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - Moomoo
Wed, 05 Aug 2026 18:29:23 GMTRigel Pharmaceuticals: The Easy Money Has Been Made (Rating Downgrade) - Seeking Alpha
Wed, 05 Aug 2026 12:30:00 GMTRigel Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Wed, 05 Aug 2026 07:00:00 GMTRigel Pharma's Q2 beats on TAVALISSE sales but GAVRETO decline and cautious outlook lead to Hold rating. - Pluang

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rigel Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.